37
Participants
Start Date
July 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Placebo
A total of 4 doses were administered.
Dupilumab
A total of 4 doses were administered.
Background treatment
Participants were required to apply stable doses of an additive-free, basic bland emollient on the affected areas of the skin twice daily throughout the study.
Berlin
Berlin
Kogarah
Woolloongabba
Carlton
Nedlands
Hanover
Bonn
Gera
Münster
Sydenham
Caversham
Auckland
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY